Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helle Westergren Hendel

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Cancer|January 10, 2022
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanomaEva Ellebaek, Aimilia Schina, Rikke Andersen, et al.
Danish Medical Journal|December 3, 2016
Routine X-ray of the chest is not justified in staging of cutaneous melanoma patientsCaroline Asirvatham Gjørup, Helle Westergren Hendel, Rita Kaae Pilegaard, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytesTroels Holz Borch, Rikke Andersen, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|June 27, 2012
Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trialLouise Wichmann Matthiessen, Helle Hjorth Johannesen, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2012
Observer variability in a phase II trial - assessing consistency in RECIST applicationKristin Skougaard, Mark James Dusgaard McCullagh, Dorte Nielsen, et al.
Head & Neck|December 16, 2018
The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancerChristina Caroline Plaschke, Helle Hjorth Johannesen, Rasmus Hvass Hansen, et al.
Cancer Treatment Reviews|August 3, 2010
Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approachKim Francis Andersen, Rahim Altaf, Anders Krarup-Hansen, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 7, 2020
Automated synthesis of <sup>68</sup> Ga/<sup>177</sup> Lu-PSMA on the Trasis miniAllinOneMikkel A Sørensen, Valdemar L Andersen, Helle Westergren Hendel, et al.
Cancers|March 13, 2024
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced PseudoprogressionSif Homburg, Charlotte Birk Christensen, Magnus Pedersen, et al.
Cancer Medicine|June 20, 2014
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Helle Hjorth Johannesen, Dorte Nielsen, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Cancer|January 10, 2022
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanomaEva Ellebaek, Aimilia Schina, Rikke Andersen, et al.
Danish Medical Journal|December 3, 2016
Routine X-ray of the chest is not justified in staging of cutaneous melanoma patientsCaroline Asirvatham Gjørup, Helle Westergren Hendel, Rita Kaae Pilegaard, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Complete metabolic response as early predictor of long-term efficacy after adoptive T cell therapy using tumor-infiltrating lymphocytesTroels Holz Borch, Rikke Andersen, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|June 27, 2012
Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trialLouise Wichmann Matthiessen, Helle Hjorth Johannesen, Helle Westergren Hendel, et al.
Acta Oncologica (Stockholm, Sweden)|March 22, 2012
Observer variability in a phase II trial - assessing consistency in RECIST applicationKristin Skougaard, Mark James Dusgaard McCullagh, Dorte Nielsen, et al.
Head & Neck|December 16, 2018
The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancerChristina Caroline Plaschke, Helle Hjorth Johannesen, Rasmus Hvass Hansen, et al.
Cancer Treatment Reviews|August 3, 2010
Malignant pheochromocytomas and paragangliomas - the importance of a multidisciplinary approachKim Francis Andersen, Rahim Altaf, Anders Krarup-Hansen, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 7, 2020
Automated synthesis of <sup>68</sup> Ga/<sup>177</sup> Lu-PSMA on the Trasis miniAllinOneMikkel A Sørensen, Valdemar L Andersen, Helle Westergren Hendel, et al.
Cancers|March 13, 2024
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced PseudoprogressionSif Homburg, Charlotte Birk Christensen, Magnus Pedersen, et al.
Cancer Medicine|June 20, 2014
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Helle Hjorth Johannesen, Dorte Nielsen, et al.
Pageof 3